Nikola Besic

Prof. Nikola Besic

Attending Surgeon
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Thyroid®
Verified
Journal Article
Closed access
NBNikola Besic
Nikola Besic
BGBarbara Gazic
Barbara Gazic
Background: Despite surgical treatment, chemotherapy, and/or radiotherapy, the vast majority of patients with anaplastic thyroid carcinoma (ATC) have a dismal prognosis. Better knowledge of the frequency of metastases to different sites might help us to perform the appropriate diagnostic tests before treatment and during the course of the disease. The aim of this study was to determine the frequency of metastases from ATC in different sites as found at autopsy. Methods: Altogether, 205 patients were treated for ATC at our institute during the years 1972–2008. Autopsy was performed in 45 cases (30 females, 15 males; median age 66 years). The relative frequencies of metastases in different sites were analyzed using descriptive statistics. Results: Altogether, 41 cases (91%) had metastases at autopsy. The most common sites of metastases were the lungs (78%), intrathoracic lymph nodes (58%), neck lymph nodes (51%), pleura (29%), adrenal glands (24%), liver (20%), brain (18%), heart (18%), and retroperitoneal lymph nodes (18%). Less common sites of distant metastases were the pericardium (13%), bones (13%), kidneys (13%), mesentery or peritoneum (13%), skin (9%), pancreas (4%), stomach (4%), diaphragm (4%), pituitary gland (2%), ovary (2%), jejunum (2%), axillary lymph nodes (2%), and gingival mucosa (2%). Both distant and regional metastases were present in 23 cases, while only distant metastases were present in 18 cases. An extensive local infiltration of the primary tumor was found in 76% of the cases. The total number of the involved organs and lymph node basins were 123 and 58, respectively. The mean number of metastatic sites was 4.02±2.75. Lung metastases were present in 34 of 38 (89%) of our patients who had distant metastases found at autopsy. Of these 34 patients, 27 were known to have lung metastases when they were alive. Conclusion: Two or more metastatic sites were found at autopsy in 84% of cases. The most common metastatic sites are lungs, followed by the intrathoracic and neck lymph nodes.

15 December 2004 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
NBNikola Besic
Nikola Besic
MHMarko Hocevar
Marko Hocevar
JZJanez Zgajnar
Janez Zgajnar
APAna Pogacnik
Ana Pogacnik
SGSnjezana Grazio-Frkovic
Snjezana Grazio-Frkovic
MAMarija Auersperg
Marija Auersperg

1 June 2003 in Thyroid®
Verified
Journal Article
Closed access
NBNikola Besic
Nikola Besic
BVBarbara Vidergar-Kralj
Barbara Vidergar-Kralj
SFSnjezana Frkovic-Grazio
Snjezana Frkovic-Grazio
TMTadeja Movrin-Stanovnik
Tadeja Movrin-Stanovnik
MAMarija Auersperg
Marija Auersperg
It is generally believed that Hürthle cell thyroid carcinoma (HCTC) does not accumulate radioactive iodine (RAI). The aim of our retrospective study was to find out if, after thyroid surgery and RAI ablation of the thyroid remnant, the metastatic or recurrent HCTC accumulates RAI. We reviewed the charts of 48 patients with histopathologically verified HCTC, who were treated at the Institute of Oncology in Ljubljana, Slovenia, from 1972 to 2000. In 16 patients (11 women, five men; 47-77 years old), who had distant metastases at presentation (eight patients) or recurrence (eight patients), whole-body RAI scanning was performed after the withdrawal of thyroid hormone replacement. Whenever RAI uptake was confirmed, the therapy with 5.6 GBq of RAI was performed. In 11 of 16 patients, the uptake (range 0.1-12%) of RAI was confirmed. Altogether, 46 therapeutic applications of RAI were given. We conclude that whole-body scanning with RAI should be performed in HCTC. RAI may be effective in the treatment of HCTC.

29 November 2007 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
NBNikola Besic
Nikola Besic
GPGasper Pilko
Gasper Pilko
RPRok Petric
Rok Petric
MHMarko Hocevar
Marko Hocevar
JZJanez Zgajnar
Janez Zgajnar

12 July 2011 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
RPRok Petric
Rok Petric
APAndraz Perhavec
Andraz Perhavec
BGBarbara Gazic
Barbara Gazic
NBNikola Besic
Nikola Besic

1 November 2002 in European Radiology
Verified
Journal Article
Closed access
PDF file
NBNikola Besic
Nikola Besic
JZJ. Zgajnar
J. Zgajnar
MHM. Hocevar
M. Hocevar
MRM. Rener
M. Rener
SFS. Frkovic-Grazio
S. Frkovic-Grazio
JLJ. Lindtner
J. Lindtner